GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pro Medicus Ltd (OTCPK:PMCUF) » Definitions » EBITDA Margin %

Pro Medicus (Pro Medicus) EBITDA Margin % : 71.96% (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Pro Medicus EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Pro Medicus's EBITDA for the six months ended in Dec. 2023 was $35.68 Mil. Pro Medicus's Revenue for the six months ended in Dec. 2023 was $49.58 Mil. Therefore, Pro Medicus's EBITDA margin for the quarter that ended in Dec. 2023 was 71.96%.


Pro Medicus EBITDA Margin % Historical Data

The historical data trend for Pro Medicus's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro Medicus EBITDA Margin % Chart

Pro Medicus Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 62.95 66.41 73.02 74.56 73.47

Pro Medicus Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.50 76.42 72.22 74.52 71.96

Competitive Comparison of Pro Medicus's EBITDA Margin %

For the Health Information Services subindustry, Pro Medicus's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pro Medicus's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Pro Medicus's EBITDA Margin % falls into.



Pro Medicus EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Pro Medicus's EBITDA Margin % for the fiscal year that ended in Jun. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=61.535/83.75
=73.47 %

Pro Medicus's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=35.677/49.581
=71.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pro Medicus  (OTCPK:PMCUF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Pro Medicus EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Pro Medicus's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pro Medicus (Pro Medicus) Business Description

Traded in Other Exchanges
Address
450 Swan Street, Richmond, Melbourne, VIC, AUS, 3121
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.

Pro Medicus (Pro Medicus) Headlines

From GuruFocus

Visage 7 Named Best in KLAS 2023

By PRNewswire PRNewswire 02-08-2023

Visage Soars with CloudPACS at RSNA 2023

By PRNewswire 11-14-2023

Visage Signs Partners HealthCare

By PRNewswire PRNewswire 01-17-2019

Visage Signs Ludwig-Maximilians-Universit�t for PACS

By PRNewswire PRNewswire 10-16-2020

Visage 7: Platform for the Future-Powered by Speed at RSNA 2019

By PRNewswire PRNewswire 11-15-2019

Visage Announces Support of Amazon HealthLake Imaging

By PRNewswire PRNewswire 11-27-2022

Visage Powers CloudPACS at HIMSS 2021

By PRNewswire PRNewswire 08-05-2021

Enterprise Imaging Advances with Visage at SIIM 2019

By PRNewswire PRNewswire 06-20-2019

Visage Introduces Semantic Annotations for Visage 7

By PRNewswire PRNewswire 12-01-2019

Breast Imaging Excels with Visage at 2018 SBI

By PRNewswire PRNewswire 04-12-2018